Nicox launches commercial operations in Germany
June 29, 2014
Sophia Antipolis, France.
Nicox S.A. (NYSE Euronext Paris: COX), the international ophthalmic company, today announced the launch of its German operations. Nicox is now promoting and selling Xailin™, a new range of tear lubricants for relief of dry eye symptoms (medical devices), and AdenoPlus®, an in vitro diagnostic medical device (IVDMD) to help the differential diagnosis of acute conjunctivitis, through its own sales force in Germany.
In line with its strategy, Nicox has been establishing its own commercial infrastructure in the United States and the five largest European markets. The first Xailin™ products, as well as AdenoPlus®, were launched in the UK, Italy, Spain and France in March 2014. In Germany, Nicox appointed Torsten Cornelius as Country Manager in April 2014, to recruit and lead the Group’s German sales force. Overall, the European commercial team had 99 employees at the end of June 2014.
Torsten Cornelius brings over 17 years of commercial and market development experience in the pharmaceutical industry, mainly with Alcon, Pfizer and Biogen Idec. He held different commercial positions in different therapeutic areas including ophthalmology and brings significant experience in Sales Force Management.